Paclitaxel Exposure and Dosage of Drug-coated Devices for the Treatment of Femoropopliteal Peripheral Artery Disease

The role of paclitaxel in the treatment of femoropopliteal peripheral arterial disease is currently ambiguous. A summary-level meta-analysis of randomised trials published in 2018 demonstrated that paclitaxel-coated devices were associated with an increased all-cause mortality in those who underwent...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ceazón T Edwards, Peter A Schneider, Cindy Huynh
Format: article
Langue:EN
Publié: Radcliffe Medical Media 2021
Sujets:
Accès en ligne:https://doaj.org/article/a60b7e2b755e4b9aa004805cc787644a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!